Nvidia Corp vs 10x Genomics, Inc.
NVDA vs TXG — side-by-side comparison from reported financials. NVDA leads 6, TXG leads 1 of 7 comparable metrics.
Nvidia Corp
NVDA · Technology
$229.39-0.47%Mixed
10x Genomics, Inc.
TXG · Technology
$81.05+4.88%Strained
| Metric | NVDA | TXG |
|---|---|---|
| Price | $229.39 | $81.05 |
| Market cap | $5.54T | $10.6B |
| Revenue (TTM) | $303B | $617M |
| Revenue growth | +100.0% | +7.6% |
| Net margin | 63.7% | -12.2% |
| Free cash flow | $127B | $121M |
| Net cash (debt) | $2.14B | — |
| 1-year price return | +19.1% | +592.1% |
| P/E | 28.6 | — |
| P/E vs own history (cheap-side %) | 96% | — |
| Dividend yield | 0.12% | — |
| Return on equity | 110% | -9% |
| CV checks passed | 10 of 11 | 4 of 11 |
| Employees | 42,000 | 1,178 |
Full résumé-style profiles: NVDA CV · TXG CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.